Karriereverlauf von Sharon Elkobi
Ehemalige bekannte Positionen von Sharon Elkobi
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CHEMOMAB THERAPEUTICS LTD. | Investor Relations Contact | 01.01.2019 | - |
| Corporate Officer/Principal | 01.01.2019 | 01.10.2022 | |
Neurim Pharmaceuticals Ltd.
 Neurim Pharmaceuticals Ltd. BiotechnologyHealth Technology Neurim Pharmaceuticals Ltd. is a neuroscience drug discovery and development company. The company provides Circadin, a prolonged release melatonin for insomnia. Its products include orlogin, for circadian rhythm disorders; Neu-120, which has been developed as adjunct therapy to levodopa in patients with motor fluctuations; Neu-P11, a melatonin agonist binds with high affinity to melatonin receptors; and Neu-105 for the treatment of asthma. The company was founded in 1991 by Nava Zisapel and Yehuda Zisapel and is headquartered in Tel-Aviv, Israel. | Corporate Officer/Principal | - | - |
Ausbildung von Sharon Elkobi
| Tel-Aviv University | Graduate Degree |
Statistik
International
| Israel | 4 |
Operativ
| Corporate Officer/Principal | 2 |
| Investor Relations Contact | 1 |
| Graduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CHEMOMAB THERAPEUTICS LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Neurim Pharmaceuticals Ltd.
Neurim Pharmaceuticals Ltd. BiotechnologyHealth Technology Neurim Pharmaceuticals Ltd. is a neuroscience drug discovery and development company. The company provides Circadin, a prolonged release melatonin for insomnia. Its products include orlogin, for circadian rhythm disorders; Neu-120, which has been developed as adjunct therapy to levodopa in patients with motor fluctuations; Neu-P11, a melatonin agonist binds with high affinity to melatonin receptors; and Neu-105 for the treatment of asthma. The company was founded in 1991 by Nava Zisapel and Yehuda Zisapel and is headquartered in Tel-Aviv, Israel. | Health Technology |
- Börse
- Insiders
- Sharon Elkobi
- Erfahrung
